Theme: Novel Discoveries for Diagnosis and Prevention of Breast Cancer

Breast Cancer Care 2019

Breast Cancer Care 2019

Details of Breast Cancer Care 2019 in Canada:

Conference Name Place Date
Breast Cancer Care- 2019 Vancouver, Canada  October 23-24, 2019

Theme: Novel Discoveries for Diagnosis and Prevention of Breast Cancer

Conference Series LLC Ltd  invites all the participants from all over the world to attend 11th Global Care Conference on Breast Cancer Therapies & Nursing Care" during October 23-24, 2019 in Vancouver, Canada Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme for the conference this year is Novel Discoveries for Diagnosis and Prevention of Breast Cancer” promises an outstanding scientific program featuring many well-known and thought-provoking speakers.

Breast cancer is the abnormal growth of the cells lining the breast lobules or ducts. These cells grow uncontrollably and have the potential to spread to other parts of the body. Both men and women can develop breast cancer, although it is uncommon in men.

Breast Cancer Care 2019 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis of Breast Cancer, as well as related Genetics, Pathophysiology, Epidemiology, Clinical Reports etc. The shift in medicine and healthcare from management of disease towards promoting wellness is a keystone in addressing the upstream caused of disease and ensuring that all women have equal opportunities.  Therefore, it is very appropriate to bring together the experts in the field from all over the globe as we share experiences and knowledge and work together on reducing the risk and creating awareness of Breast Cancer.

Who should attend?

Breast Cancer Care 2019 is an expertise meet in the field of Cancer  where oncologists, scientists, researchers, medical students, pharmacists, R& D scholars, medical professors, gynecologists, molecular biologists, bioinformatics students and professors, radiologists, cancer research institutes to exchange ideas, communicate & discuss the research work and about new advancements in the Breast cancer care and treatment.

Target Audience:


Radiation Oncologist

Radiation Therapist

Medical Oncologist

Breast Care Nurse


Reconstructive (plastic) Surgeon

Lymphoedema Therapist

Breast Cancer Surgeons, pathologists

Nurse Practitioners/Nurses

Healthcare Faculty

Medical Colleges

Healthcare Associations and Societies

Business Entrepreneurs

Training Institutes

Manufacturing Medical Devices Companies

Data Management Companies

Why to attend???

With members from around the world focused on learning about Breast Cancer and treatment and who tackle key issues facing patients throughout the continuum of the breast cancer journey; this is your best opportunity to reach the largest assemblage of participants from the Breast Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in breast cancer, woman psychology, women disorders are hallmarks of this conference.


All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.

Each abstract will receive a DOI number provided by Cross Ref

Opportunity to conduct Workshop with your team members

One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.

Opportunity to chair a session.

Certification by the organizing committee.

Individual keynote Page will be created to get more visibility for your scientific research.

Huge Benefits on Group Registration and much more.


Conference Series LLC Ltd  invites all the participants from all over the world to attend “11th Global Care Conference on Breast Cancer Therapies and Nursing Care” during October 23-24, 2019 in Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme for the conferen "Novel Discoveries for Diagnosis and Prevention of Breast Cancer” promises an outstanding scientific program featuring many well-known and thought-provoking speakers.

Breast Cancer Care 2019 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis and management of Breast Cancer, Pathophysiology, Epidemiology , Chemotherapy, prevention and management, Clinical tails in Breast Cancer, etc.c


Track 1: Clinical Staging of Breast Cancer

 The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics. The earliest stage breast cancers are stage 0 (carcinoma in situ). It then ranges from stage I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage.


Track 2: Breast Cancer Radiation Therapy

Radiation therapy also called radiotherapy uses high-energy rays to kill cancer cells. It affects cells only in the part of the body that is treated with the radiation. Breast cancer radiation therapy may be used to destroy any remaining mutated cells that remain in the breast or armpit area after surgery. There are two main kinds of radiation therapy that may be considered
External Beam Breast Cancer Radiation (Traditional cancer-killing rays delivered by a large machine)
Internal Breast Cancer Radiation (Newer treatments that inject radioactive cancer-killing treatments only in the affected area)


Track 3: Breast Cancer during Pregnancy

Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy or in the first postpartum year.  Breast cancer affects approximately 1 in 3000 pregnant women and is the second most common malignancy affecting pregnancy. The average age of women with Pregnancy-associated breast cancer is 32 to 38 years.  Only 6.5% of all cases of breast cancer affect women age < 40 years.  As more women are delaying childbearing, and as breast cancer rates continue to raise, more diagnoses of Pregnancy-associated breast cancer are anticipated. However, because Pregnancy-associated breast cancer is a relatively rare event surrounded by multiple variables, few studies address the best management and treatment options.


Track 4: Stemcells in Breast Cancer : Latest Research

Cancer stem cells are rare immortal cells within a tumor that can both self-renew by dividing and give rise to many cell types that constitute the tumor, and can therefore form tumors. Such cells have been found in various types of human tumors and might be attractive targets for cancer treatment. Since the introduction of the "cancer stem cell" theory, significant developments have been made in the understanding of cancer and the heterogenic structure of tumors. Although uncertainties about breast cancer stem cells exist, many of researchers believe that cancer stem cells should be considered as possible therapeutic targets.


Track 5: Mastectomy

Mastectomy is the removal of the whole breast. There are five different types of mastectomy: "simple" or "total" mastectomy, modified radical mastectomy, radical mastectomy, partial mastectomy, and subcutaneous (nipple-sparing) mastectomy.


Track 6: Breast Cancer in Male

Male breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. Most male breast cancer begins in cells lining the ducts. It is very rare and usually affects older men.


Track 7: Clinical Trials and Research in Breast Cancer

Clinical trials are research studies that test new treatments to see how well they work. They are an essential part of our quest to find better ways to prevent, treat, and cure cancer. Almost every cancer treatment patients receive today is the result of a clinical trial. There are several kinds of clinical trials for cancer. Some look at new therapies that may be able to help treat or potentially cure the disease. Others study therapies to see whether they produce fewer side effects than what’s currently used to treat the disease. Still others may focus on improving quality of life for people who have already had cancer treatment or are living with cancer.


Track 8: Genetics of Breast Cancer, Therapeutics & New Methods

The genetic variation can cause Breast Cancer hereditary, new therapeutics innovations are incorporated. New targeted drugs can rectify the genetic cause says research. The rest of the therapeutics and treatment methods are widely in practice. New Innovations and researches are discussed in the session. We welcome researches under genetics of breast cancer, therapeutics and new methods and related topics.


Track 9: Chemotherapy for Breast Cancer

Chemotherapy treatment uses medicine to weaken and destroy cancer cells in the body, including cells at the original cancer site and any cancer cells that may have spread to another part of the body. Chemotherapy affects the whole body by going through the bloodstream. There are quite a few chemotherapy medicines. In many cases, a combination of two or more medicines will be used as chemotherapy treatment for breast cancer.


Track 10: Oncology Rehabilitation for Breast Cancer

Oncology rehabilitation includes a wide range of therapies designed to help you build strength and endurance, regain independence, reduce stress and maintain the energy to participate in daily activities. Breast cancer and its treatment may affect your physical functioning and energy. For instance, many breast cancer treatments decrease estrogen in the body, which  may decrease bone density. Exercise may be used to promote bone density and help lower the risk of breast cancer recurrence. Exercise may also help you manage treatment-related fatigue, especially during radiation treatments.


Track 11: Breast Cancer Prevention and Control

Breast cancer is the top cancer in women both in the developed and the developing world. The incidence of breast cancer is increasing in the developing world due to increase life expectancy, increase urbanization and adoption of western lifestyles. Although some risk reduction might be achieved with prevention, these strategies cannot eliminate the majority of breast cancers that develop in low- and middle-income countries where breast cancer is diagnosed in very late stages. Therefore, early detection in order to improve breast cancer outcome and survival remains the cornerstone of breast cancer control.

Track 12: Breast Imaging with Shearware Elastography

A propelled ultrasound method is diminishing false encouraging points in bosom imaging. The innovation, ShearWave Elastography SWE, has been appeared to decrease the quantity of benevolent sores inaccurately hailed for biopsy. Clinical bosom conclusion is to some extent in light of the solidness or hardness of a discernible mass, which gives data about its etiology. At the point when the solidness of the sore and its encompassing tissue are evaluated with ShearWave Elastography, a doctor can utilize that data for the finding. In cases at our facility in Florida, these estimations have made it conceivable to dependably downsize a sonographic injury from one of low doubt requiring biopsy named Breast Imaging-Reporting and Data System, or BI-RADS, 4a to one of low doubt not requiring biopsy named BI-RADS 2 or 3.


Track 13: Clinical Implications of Breast Capsulectomy

Plastic specialists routinely submit breast capsulectomy surgical examples for pathologic assessment. Be that as it may, clinically noteworthy discoveries are once in a while recognized. With an end goal to diminish social insurance costs and the pointless utilization of healing facility assets, this review audits the adequacy of submitting breast capsulectomy examples for pathological examination.


Track 14: Radiation for Metastatic Breast Cancer

Stage IV breast cancer are treated with systemic therapy. This may include hormone therapy, chemotherapy, targeted therapy, or some combination of these. Local treatments such as surgery or radiation might also be used to help prevent or treat symptoms.


Track 15: Prognosis and Survival for Breast Cancer

A prognosis is the doctor’s best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type, stage and characteristics of your cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis. A prognostic factor is an aspect of the cancer or a characteristic of the person that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis. Doctors use different prognostic and predictive factors for newly diagnosed and recurrent breast cancers.


Track 16: Breast Cancer Surgery Choices

Prevention of cancer recurrence is the top priority when it comes to breast cancer surgery. The goal is to remove the tumor so that it won't reappear later in your breast, or spread to and appear in other parts of your body. Before having the surgery for breast cancer, taking some time to learn about the different types of procedures is must.


Track 17: Breast Cancer-Present Perspective

At least one in nine women develops breast cancer at some stage in their life. About 48,000 cases occur in the United Kingdom every year. Mostly develops in women over the age of 50 but younger women are also sometimes affected. Breast cancer can also develop in men, but this is rare. Breast cancer develops from a cancerous cell which develops in the lining of a mammary duct or a lobule in one of the breasts. It follows the classic progression though it often becomes systemic or widespread in the early onset of the disease. In 2012, the latest year for which information is accessible, in excess of 1.7 million ladies worldwide were determined to have Breast Cancer.


Track 18: Tubular Carcinoma of the Breast

Tubular carcinoma of the breast is a subtype of invasive ductal carcinoma(cancer that begins inside the breast's milk duct and spreads beyond it into healthy tissue). Tubular carcinomas are usually small (about 1 cm or less) and made up of tube-shaped structures called "tubules." These tumors tend to be low-grade, meaning that their cells look somewhat similar to normal, healthy cells and tend to grow slowly.


Track 19: Early Detection and Diagnosis in Breast Cancer

Breast cancer is the most common type of cancer among women in the United States. Early detection is key in the treatment of breast cancer. There are steps you can take to detect breast cancer early when it is most treatable. The most important screening test for breast cancer is the mammogram. A mammogram is an X-ray of the breast. It can detect breast cancer up to two years before the tumor can be felt by you or your doctor. Women age 40 - 45 or older who are at average risk of breast cancer should have a mammogram once a year. Women at high risk should have yearly mammograms along with an MRI starting at age 30.


Track 20: Breast Cancer Reports Case Studies

Breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death among them worldwide. It includes a heterogeneous collection of diseases with various histologically defined subsets, clinical presentations, responses to treatment and outcomes. A case study is a research method involving an up-close, in-depth, and detailed examination of a subject of study, as well as its related contextual conditions. Case studies can be produced by following a formal research method.


Track 21: Breast Cancer Pathology

When the breast is biopsied, the samples taken will be studied under the microscope by a specialized doctor with many years of training called a pathologist. The pathologist sends the doctor a report that gives a diagnosis for each sample taken. Information in this report will be used to help manage the patient’s care. The questions and answers that follow are meant to help you understand medical language you might find in the pathology report from a breast biopsy, such as a needle biopsy or an excision biopsy.


Track 22: Breast Cancer Biomarkers

A biomarker is a substance in a person’s blood, urine, or other body fluids. It can also be found in or on the tumor. A biomarker, sometimes called a tumor marker, is made by the tumor or by the body in response to the cancer. Biomarkers help doctors learn more about each person’s cancer so they can recommend the best treatment options for each patient. The success of breast cancer therapy is ultimately defined by clinical endpoints such as survival. It is valuable to have biomarkers that can predict the most efficacious therapies or measure response to therapy early in the course of treatment. Molecular imaging has a promising role in complementing and overcoming some of the limitations of traditional biomarkers by providing the ability to perform noninvasive, repeatable whole-body assessments.


Track 23: Breast Pathology Nursing

Timely access to a breast care nurse can greatly assist women going through treatment for breast cancer. Breast care nurses improve the continuity of care for women, and provide im..portant information, support and referral for a wide range of needs experienced by women


Track 24: Metastasis of Breast Cancer 

Metastatic breast cancer (also called stage IV) is breast cancer that has spread to another part of the body, most commonly the liver, brain, bones, or lungs. Cancer cells can break away from the original tumor in the breast and travel to other parts of the body through the bloodstream or the lymphatic system, which is a large network of nodes and vessels that works to remove bacteria, viruses, and cellular waste products. Breast cancer can come back in another part of the body months or years after the original diagnosis and treatment. Nearly 30% of women diagnosed with early-stage breast cancer will develop metastatic disease.


Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women; however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular carcinoma and invasive ductal carcinoma.

The global breast cancer market covers various diagnostic technologies and therapeutic drugs. Diagnostic segment is further sub-segmented into various tests which are used to diagnose breast cancer. Some of the major diagnostic tests are biopsy, mammography, MRI, etc. Therapeutic segment covers hormone therapies and chemotherapy drugs. Some of the major drugs are Trastuzumab, Bevacizumab, Anastrozole, Capecitabine, Carboplatin, Denosumab, Docetaxel, Doxorubicin, Eribulin, Exemestane, Fluorouracil, Fulvestrant, Gemcitabine, Ixabepilone, Lapatinib, Letrozole, Methotrexate, Paclitaxel and Tamoxifen.

Breast cancer is the most commonly occurring cancer in women accounting for 46,000 new cases in 2005. In 2003 there were an estimated 172,000 women living in the UK with a history of breast cancer. The rates have been steadily increasing over the past 10–15 years but they may now be stabilizing. Only a small number of cases, less than 1% of the total, occur in men. The numbers of cases of breast cancer are highest in the screened age group, 50 to 69 years, but the rates are highest in those aged over 85 years. It is estimated that 5% of women have metastases at diagnosis and a further 35% will develop them over the following 10 years. There is little geographical variation in the incidence rates across the country but rates are highest in those in higher socioeconomic groups. The incidence in the UK is higher than other countries, in particularly those in Eastern Europe and the risk of developing breast cancer appears to increase in those who move from a lower incidence country to the UK.

Importance and Scope:

Breast cancer is the most common cause of death in women. Research on breast cancer is rapidly progressing, yet the systematic application of current knowledge to improve patient care remains a formidable challenge. Breast Cancer Care-2019 is the premier event that brings together a unique and International mix of experts, Surgical and radiation oncologists, health care professionals, scientific researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations in the diagnosis and treatment for breast cancer. 


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 23-24, 2019
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View